首页> 外文期刊>Cells tissues organs >Characterization of osteogenically induced adipose tissue-derived precursor cells in 2-dimensional and 3-dimensional environments.
【24h】

Characterization of osteogenically induced adipose tissue-derived precursor cells in 2-dimensional and 3-dimensional environments.

机译:在二维和三维环境中骨源性诱导的脂肪组织来源的前体细胞的表征。

获取原文
获取原文并翻译 | 示例
           

摘要

Earlier reports on a putative precursor cell population in adipose tissue showed differentiation along several mesodermal lineages, leading some to think that adipose tissue can be a source of cells applicable in regenerative medicine. However, characterizations of these adipose-derived precursor cells (ADPC) in the 3-dimensional (3-D) environment, especially within the area of bone-specific composite scaffolds, have been lacking. In this study, ADPC plated on culture flasks or seeded on medical grade polycaprolactone-tricalcium phosphate scaffolds (mPCL-CaP) were able to differentiate along the osteogenic lineages in both 2-D and 3-D environments as assessed with immunohistochemistry of osteo-related proteins, reverse transcriptase-polymerase chain reactions and alkaline phosphatase assay. The mPCL-CaP scaffolds provided adipose-derived cells (ADC) with a suitable environment as determined by DNA and metabolic assays, light, confocal and scanning electron microscopy. Flow cytometry revealed ADC to be CD29+, CD44+, CD73+, CD90+ and CD14-, CD31-, CD34-, CD45-, CD71-, and therefore showed the absence of hematopoietic stem cells but possibly the presence of pericytes and mescenchymal stem cells with osteogenic potential. The results of this study demonstrated the potential of using ADPC in combination with mPCL-CaP scaffolds for bone regenerative medicine.
机译:较早的关于脂肪组织中假定的前体细胞群体的报告显示沿几种中胚层谱系分化,导致一些人认为脂肪组织可以是可用于再生医学的细胞来源。但是,这些脂肪来源的前体细胞(ADPC)在3维(3-D)环境中,尤其是在骨特异性复合支架区域内的表征尚缺乏。在这项研究中,ADPC接种在培养瓶上或接种在医用级聚己内酯-磷酸三钙支架(mPCL-CaP)上,能够通过骨相关免疫组织化学评估在2-D和3-D环境中沿成骨谱系分化。蛋白,逆转录聚合酶链反应和碱性磷酸酶测定。 mPCL-CaP支架为脂肪来源的细胞(ADC)提供了合适的环境,该环境可以通过DNA和代谢测定,光,共聚焦和扫描电子显微镜确定。流式细胞仪显示ADC为CD29 +,CD44 +,CD73 +,CD90 +和CD14-,CD31-,CD34-,CD45-,CD71-,因此显示不存在造血干细胞,但可能存在具有成骨性的周细胞和间充质干细胞潜在。这项研究的结果表明,将ADPC与mPCL-CaP支架组合使用可用于骨再生药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号